آمار
| تعداد نشریات | 21 |
| تعداد شماره‌ها | 820 |
| تعداد مقالات | 7,387 |
| تعداد مشاهده مقاله | 6,442,979 |
| تعداد دریافت فایل اصل مقاله | 2,175,329 |
Concurrent Evaluation of the Expression and Methylation of Secreted Frizzled-Related Protein 2 along with Beta-Catenin Expression in Patients with non-M3 Acute Myeloid Leukemia | ||
| Iranian Journal of Medical Sciences | ||
| مقالات آماده انتشار، اصلاح شده برای چاپ، انتشار آنلاین از تاریخ 22 آذر 1399 اصل مقاله (938.9 K) | ||
| نوع مقاله: Original Article(s) | ||
| شناسه دیجیتال (DOI): 10.30476/ijms.2020.84316.1396 | ||
| نویسندگان | ||
Fatemeh Mirzaeyan 1؛ Bahram Chahardouli2؛ Amin Mirzaeian3؛ Nasrin Alizad Ghandforoush2؛ Kamran Alimoghaddam2؛ Shahrbano Rostami  2
| ||
| 1Department of Hematology and Blood Banking, School of Allied Medicine, Tehran University of Medical Sciences, Tehran, Iran | ||
| 2Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran | ||
| 3Department of Immunology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran | ||
| چکیده | ||
| Background: Wnt signaling is a critical pathway for the development of acute myeloid leukemia (AML). Some studies have evaluated the expression or methylation of secreted frizzled-related protein 2 (SFRP2) as an antagonist and beta-catenin (β-catenin) as a critical mediator of this pathway. Since we found no comprehensive study on these genes in Iran, we aimed to investigate the status of both SFRP2 expression and methylation, and also β-catenin expression, in conjunction with clinical characteristics, in Iranian patients with de novo non-M3 AML. Methods: The methylation and expression of SFRP2 were determined in 188 patients with primary non-M3 AML and 60 healthy controls who were referred to Shariati Hospital, Tehran, Iran, between January 2017 and February 2019. The methylation-specific polymerase chain reaction (PCR) and real-time quantitative PCR were used, respectively. The expression of β-catenin was explored via real-time quantitative PCR. Statistical analysis was performed using the Mann–Whitney U test (SPSS software, version 23). A P value of less than 0.05 (2-tailed) was considered significant. Results: SFRP2 mRNA showed a significant decline in the AML group compared with the controls (P<0.001). The hypermethylation of the SFRP2 promoter occurred in 25.5% (48/188) of the cases. SFRP2 expression exhibited a negative correlation with the white blood cell count (P=0.003). The expression of β-catenin increased significantly in the patients in comparison with the controls (P<0001), and a significant difference was observed between the patients who achieved complete remission and those who did not (P=0.046). Conclusion: The findings of this study showed that alterations in SFRP2 and β-catenin expression can be used as a potential biomarker for differentiating patients with new non-M3 AML from the controls. Additionally, an evaluation of β-catenin expression may be valuable in predicting complete remission in patients with non-M3 AML. | ||
| کلیدواژه‌ها | ||
| SFRP2 protein؛ Humans؛ Leukemia؛ Myeloid؛ Acute؛ beta Catenin؛ Wnt signaling pathway | ||
|
آمار تعداد مشاهده مقاله: 327 تعداد دریافت فایل اصل مقاله: 207 |
||
